{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:36:50Z","timestamp":1760647010145},"reference-count":24,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.1248\/bpb.b18-00997","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T22:08:27Z","timestamp":1556662107000},"page":"801-806","source":"Crossref","is-referenced-by-count":10,"title":["Current Status of Adverse Events Related with Opioid Analgesics in Japan: Assessment Based on Japanese Adverse Drug Event Report Database"],"prefix":"10.1248","volume":"42","author":[{"given":"Yukio","family":"Suga","sequence":"first","affiliation":[{"name":"Department of Clinical Drug Informatics, Faculty of Pharmacy, Institute of Medical, Pharmaceutical & Health Science, Kanazawa University"},{"name":"Research Promotion Committee, Japanese Society for Pharmaceutical Palliative Care and Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayako","family":"Uchida","sequence":"additional","affiliation":[{"name":"Research Promotion Committee, Japanese Society for Pharmaceutical Palliative Care and Sciences"},{"name":"Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Research Promotion Committee, Japanese Society for Pharmaceutical Palliative Care and Sciences"},{"name":"Department of Pharmacy, National Cancer Center Hospital East"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Sugawara","sequence":"additional","affiliation":[{"name":"Research Promotion Committee, Japanese Society for Pharmaceutical Palliative Care and Sciences"},{"name":"Department of Clinical Pharmacy and Pharmacology, Kagoshima University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Torigoe","sequence":"additional","affiliation":[{"name":"Research Promotion Committee, Japanese Society for Pharmaceutical Palliative Care and Sciences"},{"name":"Division of Applied Pharmaceutical Education and Research, Hoshi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Futamura","sequence":"additional","affiliation":[{"name":"Research Promotion Committee, Japanese Society for Pharmaceutical Palliative Care and Sciences"},{"name":"Department of Pharmacy, Fujita Health University Nanakuri Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Uesawa","sequence":"additional","affiliation":[{"name":"Research Promotion Committee, Japanese Society for Pharmaceutical Palliative Care and Sciences"},{"name":"Department of Medical Molecular Informatics, Meiji Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Research Promotion Committee, Japanese Society for Pharmaceutical Palliative Care and Sciences"},{"name":"Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisamitsu","family":"Takase","sequence":"additional","affiliation":[{"name":"Research Promotion Committee, Japanese Society for Pharmaceutical Palliative Care and Sciences"},{"name":"Nippon Medical School Tama-Nagayama Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Herzig SJ, Rothberg MB, Cheung M, Ngo LH, Marcantonio ER. Opioid utilization and opioid-related adverse events in nonsurgical patients in U.S. hospitals. <i>J. Hosp. Med.<\/i>, <b>9<\/b>, 73\u201381 (2014).","DOI":"10.1002\/jhm.2102"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Dart RC, Surratt HL, Cicero TJ, Parrino MW, Severtson SG, Bucher-Bartelson B, Green JL. Trends in opioid analgesic abuse and mortality in the United States. <i>N. Engl. J. Med.<\/i>, <b>372<\/b>, 241\u2013248 (2015).","DOI":"10.1056\/NEJMsa1406143"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kuehn BM. Safety plan for opioids meets resistance: opioid-linked deaths continue to soar. <i>JAMA<\/i>, <b>303<\/b>, 495\u2013497 (2010).","DOI":"10.1001\/jama.2010.71"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Fischer B, Rehm J. Deaths related to the use of prescription opioids. <i>CMAJ<\/i>, <b>181<\/b>, 881\u2013882 (2009).","DOI":"10.1503\/cmaj.091791"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Dhalla IA, Mamdani MM, Sivilotti ML, Kopp A, Qureshi O, Juurlink DN. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. <i>CMAJ<\/i>, <b>181<\/b>, 891\u2013896 (2009).","DOI":"10.1503\/cmaj.090784"},{"key":"6","unstructured":"6) Madadi P, Hildebrandt D, Lauwers AE, Koren G. Characteristics of opioid-users whose death was related to opioid-toxicity: a population-based study in Ontario, Canada. <i>PLOS ONE<\/i>, <b>8<\/b>, e60600 (2013)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Duthey B, Scholten W. Adequacy of opioid analgesic consumption at country, global, and regional levels in 2010, its relationship with development level, and changes compared with 2006. <i>J. Pain Symptom Manage.<\/i>, <b>47<\/b>, 283\u2013297 (2014).","DOI":"10.1016\/j.jpainsymman.2013.03.015"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Okie S. A flood of opioids, a rising tide of deaths. <i>N. Engl. J. Med.<\/i>, <b>363<\/b>, 1981\u20131985 (2010).","DOI":"10.1056\/NEJMp1011512"},{"key":"9","unstructured":"9) Hirooka T, Ymada M. Evaluation of risk of adverse reaction using PMDA \u2018Adverse Drug Reaction Database.\u2019 <i>Database SAS User Groups Ronbun-syu<\/i>, 263\u2013270 (2012)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nagai J, Uesawa Y, Kagaya H. Analyses of oxycodone-induced adverse effects based on the Japanese Adverse Drug Event Report Database. <i>Palliative Care Research<\/i>, <b>10<\/b>, 161\u2013168 (2015).","DOI":"10.2512\/jspm.10.161"},{"key":"11","unstructured":"11) Foundation for Promotion of Cancer Research. \u201cCANCER STATISTICS JAPAN 2017.\u201d: \u2039https:\/\/ganjoho.jp\/data\/reg_stat\/statistics\/brochure\/2017\/cancer_statistics_2017.pdf\u203a, cited March, 2018."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Zedler B, Xie L, Wang L, Joyce A, Vick C, Kariburyo F, Rajan P, Baser O, Murrelle L. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. <i>Pain Med.<\/i>, <b>15<\/b>, 1911\u20131929 (2014).","DOI":"10.1111\/pme.12480"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC. Association between opioid prescribing patterns and opioid overdose-related deaths. <i>JAMA<\/i>, <b>305<\/b>, 1315\u20131321 (2011).","DOI":"10.1001\/jama.2011.370"},{"key":"14","unstructured":"14) Barletta JF. Clinical and economic burden of opioid use for postsurgical pain: focus on ventilatory impairment and ileus. <i>Pharmacotherapy<\/i>, <b>32<\/b> (Suppl.), 12S\u201318S (2012)."},{"key":"15","unstructured":"15) De Conno F, Ripamonti C, Fagnoni E, Brunelli C, Luzzani M, Maltoni M, Arcuri E, Bertetto O; MERITO Study Group. The MERITO Study: a multicentre trial of the analgesic effect and tolerability of normal-release oral morphine during \u2018titration phase\u2019 in patients with cancer pain. <i>Palliat. Med.<\/i>, <b>22<\/b>, 214\u2013221 (2008)."},{"key":"16","unstructured":"16) Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, Mercadante S, Pasternak G, Ventafridda V, Expert Working Group of the European Association of Palliative Care Network. Strategies to manage the adverse effects of oral morphine: an evidence-based report. <i>J. Clin. Oncol.<\/i>, <b>19<\/b>, 2542\u20132554 (2001)."},{"key":"17","unstructured":"17) Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, Ripamonti CI, ESMO Guidelines Committee. Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. <i>Ann. Oncol.<\/i>, <b>29<\/b> (Suppl. 4), iv166\u2013iv191 (2018)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Mystakidou K, Tsilika E, Parpa E, Kouloulias V, Kouvaris I, Georgaki S, Vlahos L. Long-term cancer pain management in morphine pre-treated and opioid naive patients with transdermal fentanyl. <i>Int. J. Cancer<\/i>, <b>107<\/b>, 486\u2013492 (2003).","DOI":"10.1002\/ijc.11416"},{"key":"19","unstructured":"19) Donner B, Zenz M, Tryba M, Strumpf M. Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain. <i>Pain<\/i>, <b>64<\/b>, 527\u2013534 (1996)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Jumbelic MI. Deaths with transdermal fentanyl patches. <i>Am. J. Forensic Med. Pathol.<\/i>, <b>31<\/b>, 18\u201321 (2010).","DOI":"10.1097\/PAF.0b013e31818738b8"},{"key":"21","unstructured":"21) Nadpara PA, Joyce AR, Murrelle EL, Carroll NW, Carroll NV, Barnard M, Zedler B. Risk factors for serious prescription opioid-induced respiratory depression or overdose: comparison of commercially insured and veterans health affairs populations. <i>Pain Med.<\/i>, <b>19<\/b>, 79\u201396 (2018)."},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Fox LM, Hoffman RS, Vlahov D, Manini AF. Risk factors for severe respiratory depression from prescription opioid overdose. <i>Addiction<\/i>, <b>113<\/b>, 59\u201366 (2018).","DOI":"10.1111\/add.13925"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Dahan A, Yassen A, Bijl H, Romberg R, Sarton E, Teppema L, Olofsen E, Danhof M. Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats. <i>Br. J. Anaesth.<\/i>, <b>94<\/b>, 825\u2013834 (2005).","DOI":"10.1093\/bja\/aei145"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Gomes T, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. The burden of opioid-related mortality in the United States. <i>JAMA Netw. Open<\/i>, <b>1<\/b>, e180217 (2018).","DOI":"10.1001\/jamanetworkopen.2018.0217"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/5\/42_b18-00997\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,4]],"date-time":"2019-05-04T03:20:03Z","timestamp":1556940003000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/5\/42_b18-00997\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,1]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b18-00997","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,1]]}}}